Personalized Drug Therapy in Oncology: Clinical Insights and Future Perspectives

Cancer treatment has made progress through personalized medical therapies that tailor strategies based on patient characteristics. This article explores the application of personalized therapies in oncology, including biomarker-guided therapies, liquid biopsies, next-generation sequencing, personalized immunotherapy, and nanotechnology-based drug delivery. Focusing on personalized drug therapy in oncology, this article delves into its clinical application. It elaborates on the use of biomarkers to guide medication, liquid biopsy for auxiliary diagnosis, and personalized immunotherapy, showcasing their role in advancing precision medicine. At the same time, it discusses the challenges faced in this field, such as high costs and complex data processing, and looks forward to the future prospects of personalized drug therapy in oncology. Despite advancements, challenges such as high costs and complex data analysis issues still persist.